Nello Mainolfi

Chief Executive Officer

Nello Mainolfi (Chief Executive Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $9.2M of KYMR (80,000 sh across 5 lots, as filed), executed Jul 1.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 7 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$33.3M

shares × price, as filed

Last traded

Jul 7

Filed Jul 7

Median ADV $102.3M across their filed names

Open performance→

Volume by month

Buys $0 Sells $36.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 7 filings

Sector per market data · by filing · past 12 months

Most traded names

KYMR

Kymera Therapeutics, Inc. KYMR · 0 buys · 9 sells 9 filings

Recent filings

KYMRSALE Kymera Therapeutics, Inc. View filing → $6.0M
50,000 sh × $119.00
Exec Jul 7
Filed Jul 7 · 8:00 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $9.2M
80,000 sh across 5 lots
Exec Jul 1
Filed Jul 2 · 6:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $2.4M
29,064 sh across 2 lots
Exec Apr 29
Filed Apr 29 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $2.7M
29,992 sh across 4 lots
Exec Feb 25
Filed Feb 25 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $2.3M
30,000 sh across 2 lots
Exec Dec 31 2025
Filed Dec 31 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $8.9M
100,000 sh × $89.17
Exec Dec 8 2025
Filed Dec 8 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $1.8M
30,000 sh across 3 lots
Exec Oct 29 2025
Filed Oct 29 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $1.5M
30,000 sh × $49.00
Exec Sep 16 2025
Filed Sep 16 2025 · 5:30 PM ET More filings →